Flow cytometry experiments validated these data confirming the low expression of GrA and GrB but high expression of GrK in the CD103– CD8+ Trm population (Fig. 2a, b), suggesting GrK may have a selective functional role in the CD103– CD8+ Trm cell subpopulation in AD. The gene discussed is CD8A; the disease is Alzheimer disease.